Low-dose vasopressors for shock in the ICU
Part of Heart & circulation, Injuries & trauma clinical trials.
This study tests whether giving low-dose blood pressure medicines through a standard IV (instead of a larger central line) is safe and effective for patients with shock in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You do not have a central line or PICC line already in place.
- You have shock and require at least one of these medicines at a low dose: norepinephrine, phenylephrine, epinephrine, or dobutamine.
- You do not need immediate dialysis through a new catheter.
- You are not currently taking more than two blood pressure medicines to keep your blood pressure above 65.
- You are not pregnant or suspected to be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This study compares two starting doses of a medicine called norepinephrine (which helps raise blood pressure) for patients in shock. It aims to find the best dose to quickly stabilize blood pressure and improve outcomes.
This trial tests whether using a blood test called renin to guide treatment can help stabilize blood pressure in ICU patients with shock. It may help doctors choose the right medications and targets to reduce complications.
This trial studies whether aiming for a higher average blood pressure (using medicines) can better protect kidney function in critically ill adults with shock. You may be asked to have close kidney and heart monitoring while receiving blood-pressure support.
This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.
This study compares individualized blood pressure goals versus the usual (standard) targets for adults in the ICU with shock. The aim is to see whether tailored blood pressure treatment can improve outcomes by better matching each person’s needs.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.